Belgium· BE-AMP-SAM286885-00
Neupro 8 mg/24 h
A rotigotine product containing rotigotine, registered in Belgium by UCB Pharma. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Rotigotine is registered in 18 of 19 countries.
Countries holding a registration under ATC N04BC09 (rotigotine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Rotigotine · ATC N04BC09
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of rotigotine costs, country by country.
Normalised to the WHO defined daily dose (6 mg), the median price runs from $0.77 in Czechia to $4.34 in Switzerland — a ×5.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Rotigotine · price per daily dose (6 mg)
USD · FX 28 Sept 2026
- CH Switzerland$4.34
- CZ Czechia$0.77
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Rotigotine
- Manufacturer
- UCB Pharma
- Country
- Belgium (BE)
- ATC code
- N04BC09
- ATC class
- Rotigotine
- Defined daily dose
- 6 mg, TD
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb2494474
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for rotigotine.
Graded by severity as the source publishes them — 58 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Rotigotine · interactions on record
58 records
- 58 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Rotigotine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNEUPROUCB Pharma SA, Brusel
- SpainKINPARLEV 8 MG/24 H PARCHE TRANSDERMICO EFGOrion Corporation
- ItalyNEUPROUCB PHARMA S.A.
- United StatesNeuproUCB, Inc.
- PolandNeuproUCB Pharma S.A.
- NetherlandsNeupro 8 mg/24 h pleister voor transdermaal gebruikUCB Pharma S.A.
- United KingdomNeupro 1mg/24hours transdermal patchesUCB Pharma Ltd
- FinlandKinparlevOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Kinparlev, Rotigotin Gebro
- Germany · Rotigotin Luye, Rotigotin Neuraxpharm
- Denmark · Kinparlev, Rotigotine Medical Valley
- Spain · Dariante
- Finland · Kinparlev, Rotigotine Medical Valley
- France · Rotigotine Arrow
- Greece · Kinparlev
- Iceland · Neupro, Rotigotine Medical Valley
- Italy · Rotigotina Doc
- Liechtenstein · Neupro
- Luxembourg · Rotigotin Luye
- Netherlands · Rotigotine Medical Valley, Rotigotine Xiromed
- Norway · Kinparlev, Neupro
- Portugal · Kinparlev, Rotigotina Generis
- Romania · Kinparlev
- Sweden · Kinparlev, Rotigotine Medical Valley
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d96accec-ef2b-4fe2-ad27-32436c9bae31 GET /v1/drugs/d96accec-ef2b-4fe2-ad27-32436c9bae31?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Transdermal patch",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Neupro 8 mg/24 h",
"name_fr": "Neupro 8 mg/24 h",
"name_nl": "Neupro 8 mg/24 h",
"amp_code": "SAM286885-00",
"strengths": [
"18.0000",
"18.0000",
"18.0000"
],
"pack_count": 10,
"substances": [
"Rotigotine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Rotigotine",
"authorisation_numbers": [
"EU/1/05/331/010",
"EU/1/05/331/011",
"EU/1/05/331/012",
"EU/1/05/331/032",
"EU/1/05/331/033",
"EU/1/05/331/034",
"EU/1/05/331/035",
"EU/1/05/331/036",
"EU/1/05/331/037",
"EU/1/05/331/061"
]
}See everything about rotigotine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.